What's new

PSUSA/00010605/202407

PSUSA/00010605/202407

Feb 13, 2025 - 17:17
 0
PSUSA/00010605/202407
PSUSA/00010605/202407
Read More

Tags:

Previous Article

GOP moves to replace US’ EV tax credits with a US$1,000 fee

Next Article

PSUSA/00010252/202406

Related Posts

Human medicines European public assessment report (EPAR): Skytrofa (previously Lonapegsomatropin Ascendis Pharma), lonapegsomatropin, Date of authorisation: 11/01/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Questions and answers on implementation of the medical ...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Dafiro HCT, amlodipine besilate,valsartan,hydrochlorothiazide, Date of authorisation: 03/11/2009, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0